Enterobacter cloacae complex is a significant multidrug-resistant pathogen found in hospitals, prompting a study on its antimicrobial resistance and genetic factors in Brazil.
The study screened 94 clinical isolates, finding 20.2% (19 isolates) resistant to colistin, with high levels of resistance indicated by MIC values ranging from 4 to 128 µg/mL.
Genetic analysis revealed several carbapenemase and polymyxin resistance genes, along with diverse genetic profiles among the isolates, but no predominant clone was established.
Carbapenems are crucial last-resort antibiotics for treating infections from multidrug-resistant Gram-negative bacteria, but resistance through mechanisms like OprD loss and carbapenemases is a growing global concern.
A study in Brazil tested the effectiveness of three phenotypic tests—Carba NP, Blue Carba, and mCIM/eCIM—to detect carbapenemase-producing Pseudomonas species, using 127 clinical isolates.
Results showed that Carba NP had the highest sensitivity and successfully differentiated between carbapenemases types, while Blue Carba struggled with class B detection, highlighting the need for improved and more reliable resistance detection methods.
- The study assessed 502 Enterobacteriales isolates in Brazil for resistance to polymyxins, specifically colistin, revealing a 29.5% resistance rate and confirming all isolates as multidrug-resistant (MDR).
- Genetic analysis indicated that 77% of isolates harbored carbapenemase genes, with various molecular typing methods identifying significant diversity, including 51 pulsotypes and 21 sequence types (STs), notably ST437, ST258, and ST11.
- The research identified key chromosomal mutations and insertion sequences linked to increased resistance, highlighting the emergence of high-risk clones such as CC11 in Brazil, raising concerns about global implications for antibiotic resistance.
High rates of carbapenem resistance in Brazilian Pseudomonas aeruginosa are linked to a specific clone (ST277) that produces a type of carbapenemase called SPM-1.
Researchers used whole genome sequencing to analyze the genetic make-up of a plasmid containing the bla gene in these resistant isolates and found a new bla-plasmid.
The study highlights the urgent need for public health measures to track the spread of this plasmid due to its connection with a high-risk bacterial clone.
Multidrug-resistant gram-negative bacilli (GNB) are a significant global health issue, especially when linked to bloodstream infections (BSI), which worsen patient outcomes.
Whole-genome sequencing was used to study these pathogens in Brazil, revealing high-risk clones like CC258, ST79, and ST233, along with their resistance mechanisms.
Key findings included associations between specific gene variants and clones, the identification of new MDR clone ST3079, and a novel clonal profile ST848, which could inform future strategies for managing BSI and other hospital-acquired infections.
- Emergence of colistin-resistant bacteria with mobile resistance genes is a growing threat to both animals and humans involved in food production.
- The article focuses on identifying a specific plasmid that carries colistin resistance genes in poultry, highlighting its role as a new reservoir for these genes.
- Three closely related bacterial strains were isolated from cloacal swabs, and their genomes included a significant plasmid that potentially facilitates the spread of colistin resistance.